News

FDA Approves Duo-Boost: New Combo Therapy for Type 2 Diabetes

FDA · Type 2 Diabetes Mellitus · 7 min

FDA Approves RGEN-101: RareGen’s Orphan Drug for Genetic Disorder

FDA · Rare Genetic Disorders · 7 min

FDA Approves Inflammex: Novel Biologic for Ulcerative Colitis

FDA · Ulcerative Colitis · 7 min

FDA Approves Synapton: Breakthrough for Severe Alzheimer's Treatment

FDA · Alzheimer's disease · 5 min

FDA Approves Generic EpiPen: Key Details on Mylan’s Price Solution

FDA · allergy · 3 min

FDA Approves Prevnar 20 Pediatric Indication Expansion for Pneumococcal Disease

FDA · Infectious Disease · 4 min

Health Canada Approves Bracco's VUEWAY (Gadopiclenol) for Lower-Dose MRI Contrast Imaging

2 min

Salubris Biotherapeutics JK06 Shows Promise in Phase 1/2 Cancer Trial at AACR 2024

2 min

Innate Pharma IPH5201 MATISSE Phase 2 Results Selected for AACR 2026 Clinical Trials Plenary Session

3 min

Accent Therapeutics ATX-295 Shows Promising Anti-Cancer Activity in Preclinical Studies at AACR 2026

2 min

FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product for Continued U.S. Marketing

2 min

Olema Oncology Presents Palazestrant and OP-3136 Preclinical Data at AACR 2026 for Breast Cancer Treatment

EMA · 2 min